针对原发性Sjögren综合征的研究生物疗法
Shi-Hao He1, Yi-Yi Xuan1, Xu Liang1
1The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Archives of medical science : AMS
|May 17, 2024
概括
主要Sjögren综合征 (pSS) 是一种影响外分泌腺体的自身免疫性疾病. 目前的治疗方法往往是无效的,这促使人们研究针对淋巴细胞和细胞因子的新生物疗法,以改善患者的治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 自免疫性疾病 自免疫性疾病
背景情况:
- 主要Sjögren综合征 (pSS) 是一种慢性系统性自身免疫性疾病.
- 由于外分腺体的单核细胞透而导致眼睛和口腔干燥的特征.
- 目前的治疗方法基本上是缓和的,结果不令人满意.
研究的目的:
- 总结和比较现有的pSS生物疗法.
- 确定pSS的新和有效的治疗策略.
- 探索淋巴细胞和细胞因子在pSS病原和治疗中的作用.
主要方法:
- 目前关于PSS生物疗法的文献综述.
- 对B细胞向疗法和阿塔切 (T细胞调节) 的临床试验数据的分析.
- 对调查pSS中细胞因子抑制的研究进行审查.
主要成果:
- 针对B细胞的疗法显示出有希望的初步结果,需要进一步验证.
- 阿巴切通过调节T细胞功能来改善PSS严重性的疗效.
- 已经进行了细胞因子抑制试验,结果正在等待进一步分析.
结论:
- 针对免疫细胞和细胞因子的生物疗法是PSS治疗的有希望的途径.
- 进一步的研究和临床试验对于确定这些新方法的安全性和有效性至关重要.
- 对淋巴细胞和细胞因子作用的全面理解对于开发有效的pSS疗法至关重要.
更多相关视频
相关概念视频
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...


